By providing a novel nexus of regulating IGF production, GRP94 and its alterations serve as a potentially new mechanism of dysregulated growth, such as idiopathic short stature and cancer, and thereby may lead to new therapeutic interventions. The gene discussed is HSP90B1; the disease is cancer.